Brookstone Capital Management Has $1.98 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Brookstone Capital Management lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,048 shares of the exchange traded fund’s stock after selling 3,745 shares during the quarter. Brookstone Capital Management’s holdings in SPDR S&P Biotech ETF were worth $1,978,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in XBI. Eudaimonia Partners LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at $25,000. Clearstead Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth about $33,000. Advisory Alpha LLC acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth about $40,000. Stumpf Capital Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $43,000. Finally, RMR Wealth Builders bought a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $49,000.

XBI stock opened at $148.57 on Thursday. The stock’s 50 day simple moving average is $142.31 and its 200 day simple moving average is $121.50. SPDR S&P Biotech ETF has a fifty-two week low of $62.94 and a fifty-two week high of $152.70.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Article: Trading Strategy Examples and Plans

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.